Marc Beer, a businessman and philanthropist is focused now on his new endeavor with Renovia Inc. The goal isn’t just marketing better, it is now streamlined for the purpose of furthering research in medicine for women’s health. Raising more than $42 million in capital, he is on the brink of something exciting, along with his other investors. As the co-founder of Renovia Inc., Marc Beer has a huge mission on his hands.
Over the last 5 years there has been a growing interest in the research and study of pelvic floor disorders. After having closed in a few rounds of capital, the company is now in position to put more time and research into this area of interest. The study of pelvic floor disorders has opened up the opportunity for new advancements in medicine and alternative therapies.
Renovia Inc., known as a medtech company, has been working on the creation and development of the rapeutic products for this reason. These disorders affect nearly 260 million women around the world, and that number is likely to continue to grow unless advancements are made. The very first product known as Leva, received approval by the FDA back in April.
Although more funds are needed to further the development and creation of products and therapies for pelvic floor disorders, investing firms are now getting hit with questions about how investments can be made in companies like Renovia. The Longwood Fund, a healthcare-focused investment firm is a key player in this area financially. Two companies backing this fund include Ascension Ventures and Perceptive Advisors.
Although the Leva was designed, there are still further improvements that need to be made to the Leva before it can be put on the market. The ultimate end goal of Renovia Inc. is to improve the lives of women everywhere. Marc Beer, as the CEO is making great strides in continuing the effort to raise money more capital for the company. He believes that the best is yet to come for Renovia Inc., and all that has transpired so far for the company’s developments.
Marc Beer recently made statements in an interview regarding the support that they have gotten thus far from healthcare focused investors, and what the future holds for them. Driving greater knowledge in the area of pelvic floor disorders and related health problems is a great place for research to start. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing